NYSE:CVS - CVS Health Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$73.68 +0.48 (+0.66 %)
(As of 08/17/2018 04:00 PM ET)
Previous Close$73.68
Today's Range$72.77 - $74.24
52-Week Range$60.14 - $84.00
Volume7.14 million shs
Average Volume8.50 million shs
Market Capitalization$70.30 billion
P/E Ratio12.49
Dividend Yield2.79%
Beta0.96
CVS Health logoCVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order, specialty pharmacy and infusion services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services. This segment serves employers, insurance companies, unions, government employee groups, health plans, Medicare Part D plans, managed Medicaid plans, plans offered on public and private exchanges, other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Specialty, AccordantCare, SilverScript, Wellpartner, NovoLogix, Coram, Navarro Health Services, and ACS Pharmacy names. As of December 31, 2017, it had 23 retail specialty pharmacy stores, 18 specialty mail order pharmacies and 4 mail order dispensing pharmacies, and 83 branches for infusion and enteral services. The Retail/LTC segment sells prescription drugs, over-the-counter drugs, beauty products and cosmetics, personal care products, convenience foods, seasonal merchandise, and greeting cards, as well as offers photo finishing services. It has 9,803 retail stores in 49 states, the District of Columbia, Puerto Rico, and Brazil primarily under the CVS Pharmacy, CVS, CVS Pharmacy y más, Longs Drugs, Navarro Discount Pharmacy, and Drogaria Onofre names; online retail pharmacy Websites; and 37 onsite pharmacy stores, long-term care pharmacy operations, and retail health care clinics. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1892 and is headquartered in Woonsocket, Rhode Island.

Receive CVS News and Ratings via Email

Sign-up to receive the latest news and ratings for CVS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSE
Industry Drug stores & proprietary stores
Sub-IndustryDrug Retail
SectorRetail/Wholesale
SymbolNYSE:CVS
CUSIP12665010
Phone401-765-1500

Debt

Debt-to-Equity Ratio1.73
Current Ratio2.34
Quick Ratio1.87

Price-To-Earnings

Trailing P/E Ratio12.49
Forward P/E Ratio10.47
P/E Growth0.93

Sales & Book Value

Annual Sales$184.77 billion
Price / Sales0.41
Cash Flow$9.1642 per share
Price / Cash8.04
Book Value$37.21 per share
Price / Book1.98

Profitability

EPS (Most Recent Fiscal Year)$5.90
Net Income$6.62 billion
Net Margins1.61%
Return on Equity18.25%
Return on Assets5.87%

Miscellaneous

Employees246,000
Outstanding Shares1,018,060,000
Market Cap$70.30 billion

CVS Health (NYSE:CVS) Frequently Asked Questions

What is CVS Health's stock symbol?

CVS Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CVS."

How often does CVS Health pay dividends? What is the dividend yield for CVS Health?

CVS Health announced a quarterly dividend on Wednesday, July 11th. Investors of record on Wednesday, July 25th will be given a dividend of $0.50 per share on Wednesday, August 1st. This represents a $2.00 dividend on an annualized basis and a yield of 2.71%. The ex-dividend date is Tuesday, July 24th. View CVS Health's Dividend History.

How were CVS Health's earnings last quarter?

CVS Health Corp (NYSE:CVS) announced its quarterly earnings data on Wednesday, August, 8th. The pharmacy operator reported $1.69 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $1.61 by $0.08. The pharmacy operator had revenue of $46.71 billion for the quarter, compared to analysts' expectations of $46.34 billion. CVS Health had a net margin of 1.61% and a return on equity of 18.25%. CVS Health's quarterly revenue was up 2.2% compared to the same quarter last year. During the same period in the previous year, the business posted $1.33 EPS. View CVS Health's Earnings History.

When is CVS Health's next earnings date?

CVS Health is scheduled to release their next quarterly earnings announcement on Monday, November, 5th 2018. View Earnings Estimates for CVS Health.

What guidance has CVS Health issued on next quarter's earnings?

CVS Health issued an update on its FY18 earnings guidance on Wednesday, August, 8th. The company provided earnings per share (EPS) guidance of $6.98-7.08 for the period, compared to the Thomson Reuters consensus EPS estimate of $7.00. CVS Health also updated its Q3 guidance to $1.68-1.73 EPS.

What price target have analysts set for CVS?

17 Wall Street analysts have issued 12 month target prices for CVS Health's shares. Their forecasts range from $68.00 to $99.00. On average, they anticipate CVS Health's stock price to reach $86.6667 in the next twelve months. This suggests a possible upside of 17.6% from the stock's current price. View Analyst Price Targets for CVS Health.

What is the consensus analysts' recommendation for CVS Health?

17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CVS Health in the last year. There are currently 4 hold ratings, 11 buy ratings and 2 strong buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for CVS Health.

Are investors shorting CVS Health?

CVS Health saw a increase in short interest during the month of July. As of July 31st, there was short interest totalling 50,796,244 shares, an increase of 8.2% from the July 13th total of 46,962,651 shares. Based on an average trading volume of 5,911,694 shares, the days-to-cover ratio is currently 8.6 days. Approximately 5.0% of the shares of the stock are sold short. View CVS Health's Current Options Chain.

Who are some of CVS Health's key competitors?

Who are CVS Health's key executives?

CVS Health's management team includes the folowing people:
  • Mr. Larry J. Merlo, CEO & Director (Age 62)
  • Mr. David M. Denton, Exec. VP & CFO (Age 53)
  • Mr. Jonathan C. Roberts, Exec. VP & COO (Age 62)
  • Mr. Thomas Michael Moriarty, Exec. VP, Chief of Policy & External Affairs Officer and Gen. Counsel (Age 54)
  • Ms. Eva C. Boratto, Exec. VP, Controller & Chief Accounting Officer (Age 51)

Has CVS Health been receiving favorable news coverage?

Headlines about CVS stock have been trending positive this week, Accern Sentiment reports. The research firm ranks the sentiment of press coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. CVS Health earned a media and rumor sentiment score of 0.28 on Accern's scale. They also gave media headlines about the pharmacy operator an impact score of 47.35 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company's share price in the immediate future. View Recent Headlines for CVS Health.

Who are CVS Health's major shareholders?

CVS Health's stock is owned by many different of retail and institutional investors. Top institutional investors include BlackRock Inc. (7.29%), FMR LLC (2.83%), Parnassus Investments CA (1.64%), Bank of New York Mellon Corp (1.24%), Veritas Asset Management LLP (1.17%) and Dimensional Fund Advisors LP (1.07%). Company insiders that own CVS Health stock include Andrew Sussman, C David Brown II, David M Denton, Eva C Boratto, Helena Foulkes, Jonathan C Roberts, Larry J Merlo, Lisa Bisaccia, Richard J Swift, Thomas M Moriarty and Troyen A Brennan. View Institutional Ownership Trends for CVS Health.

Which major investors are selling CVS Health stock?

CVS stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Bank of America Corp DE, Bank of Montreal Can, Massachusetts Financial Services Co. MA, Canada Pension Plan Investment Board, Standard Life Aberdeen plc, American Century Companies Inc. and NN Investment Partners Holdings N.V.. Company insiders that have sold CVS Health company stock in the last year include David M Denton, Helena Foulkes, Jonathan C Roberts, Larry J Merlo, Lisa Bisaccia and Thomas M Moriarty. View Insider Buying and Selling for CVS Health.

Which major investors are buying CVS Health stock?

CVS stock was purchased by a variety of institutional investors in the last quarter, including BlackRock Inc., Charles Schwab Investment Advisory Inc., Boston Partners, Morgan Stanley, Caisse DE Depot ET Placement DU Quebec, Bank of New York Mellon Corp, Fiera Capital Corp and Natixis. View Insider Buying and Selling for CVS Health.

How do I buy shares of CVS Health?

Shares of CVS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is CVS Health's stock price today?

One share of CVS stock can currently be purchased for approximately $73.68.

How big of a company is CVS Health?

CVS Health has a market capitalization of $70.30 billion and generates $184.77 billion in revenue each year. The pharmacy operator earns $6.62 billion in net income (profit) each year or $5.90 on an earnings per share basis. CVS Health employs 246,000 workers across the globe.

How can I contact CVS Health?

CVS Health's mailing address is ONE CVS DR., WOONSOCKET RI, 02895. The pharmacy operator can be reached via phone at 401-765-1500 or via email at [email protected]


MarketBeat Community Rating for CVS Health (NYSE CVS)

Community Ranking:  3.3 out of 5 (star star star)
Outperform Votes:  984 (Vote Outperform)
Underperform Votes:  493 (Vote Underperform)
Total Votes:  1,477
MarketBeat's community ratings are surveys of what our community members think about CVS Health and other stocks. Vote "Outperform" if you believe CVS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CVS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 8/18/2018 by MarketBeat.com Staff

Featured Article: NASDAQ

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.